AI Article Synopsis
- The study investigated the genetic intratumor heterogeneity (ITH) in synchronous ductal carcinoma in situ (DCIS) and invasive breast carcinoma (IBC).
- A total of 17 lesions from 5 patients were analyzed using whole-exome sequencing, revealing unique mutations and copy number changes specific to each lesion.
- Key findings indicated that while common mutations were identified in IBC and DCIS, there were no universally mutated genes across all tumors, highlighting that some DCIS lesions may be as advanced or more advanced than the corresponding IBC.
Article Abstract
Background/aim: Intratumor heterogeneity (ITH), defined as a tumor composed of multiple subclones with different characteristics, is widely reported in invasive breast carcinoma (IBC) and ductal carcinoma in situ (DCIS). This study aimed to assess the extent of ITH in synchronous DCIS-IBC at the genetic level.
Materials And Methods: A total of 17 lesions from 5 patients were subjected to whole-exome sequencing. Nonsynonymous mutations and copy number aberrations were visualized to assess ITH.
Results: The most commonly mutated cancer-related genes in IBC and DCIS were RUNX1 (35.3%), PIK3CA (29.4%), and GATA3 (29.4%). There were no universally mutated cancer-related genes in all IBCs. All lesions harbored private mutations restricted to each lesion. Several DCIS lesions displayed a greater amount of genetic aberrations than the accompanying IBC, implying that a subset of DCIS was as advanced or more advanced than the synchronous IBC.
Conclusion: We herein demonstrated genetic ITH in DCIS lesions coexisting with IBC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.15170 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!